News
The rate of appendix cancer has tripled among Generation X and quadrupled among millennials compared to previous generations, a new study found. The study, published June 10 in Annals of Internal ...
18h
inews.co.uk on MSNI had bowel cancer at 34 – it killed my relatives, but a single test saved meThe disease runs in my family, but I'm living proof that survival rates are improving for cancer patients, thanks to medical ...
Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.
The Varian Ethos 2.0 technology is part of UH's broader cancer care initiative, which includes a new $39 million regional ...
A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, ...
Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...
Future studies will investigate long-term implications of FMT on host metabolism and immune function, and effects on brain ...
T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...
5d
SurvivorNet on MSNImmunotherapy For Small Cell Lung Cancer: Groundbreaking New Developments Offer Hope To PatientsFor the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...
A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of ...
Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...
Learn the crucial differences between IBS and colon cancer symptoms, risk factors, and treatments to protect your digestive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results